“Some days I wake up and may’t feel how far we’ve come,” said Dr. Doblin, sixty seven, who now oversees the Multidisciplinary Affiliation for Psychedelic Experiments, a multimillion greenback investigation and advocacy empire that employs a hundred thirty neuroscientists, pharmacologists and regulatory professionals Doing the job to lay the